Smad2 (fosfo Ser464) Antilichaam

Transcriptional modulator activated by TGF-beta and activin type 1 receptor kinase. SMAD2 is a receptor-regulated SMAD (R-SMAD) . May act as a tumor suppressor in colorectal carcinoma.

4087

Q15796

NP_001003652.1

Human, Mouse, Rat

Smad2 (phospho Ser465) antibody was raised against a peptide sequence around phosphorylation site of Serine 465 (C-S-S (p) -M-S) derived from Human Smad2.

Unconjugated

Primary Antibodies

Phospho-Specific

Antibodies were purified by affinity-chromatography using epitope-specific peptide.

1 mg/mL

Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

Phospho-Specific

Blue Ice

Store antibody at -20˚ C for up to one year.

52 kDa

IgG

The antibody detects endogenous levels of Smad2 only when phosphorylated at serine 465.

Western Blot: 1:500~1:1000

SMAD2

SMAD family member 2

Homo sapiens

Riggins G.J., Nat. Genet. 13:347-349 (1996) .

Zhang Y., Nature 383:168-172 (1996) .

Eppert K., Cell 86:543-552 (1996) .

HMAD-2, JV18, JV18-1, MAD, hSMAD2

WB

51173730

Liquid